Cencora report flags payer restrictions squeezing health-system pharmacy patient access

Bitget2026/10/07 16:57

Cencora published a Fall 2026 survey of 110+ US health system pharmacy leaders, flagging growth plans constrained by payer restrictions. More than half described strategies as growth-oriented; 87% prioritized pharmacy financial performance, 85% biosimilars or formulary optimization. Specialty access remained a key drag; 69% of specialty prescriptions were still dispensed outside health systems despite faster internal therapy starts. Payer network restrictions affected 77% of respondents; payer approval requirements affected 74%, limiting revenue capture from existing patient volumes. Cell and gene therapy readiness lagged; only 5% said pharmacy leads these programs despite universal pharmacy involvement among current adopters. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Goldman Sachs expects $7.5 billion in buying of gold and silver in January next year, while crude oil faces selling pressure of $7.9 billion.

金十数据•2026/11/07 03:47

Pyth October Report: ARR Jumps 18.9% as Data Expansion Accelerates

Coinpedia•2026/11/07 03:27

Elon Musk: SpaceX (SPCX.US) Q4 revenue is expected to increase by approximately 70% quarter-on-quarter, with government contract income share falling below 10%

Elon Musk stated on Friday that SpaceX (SPCX.US) will continue to reduce its dependence on U.S. government procurement contracts.

智通财经•2026/11/07 02:16

After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.

The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.

华尔街见闻•2026/11/06 23:26